Dr. Stephen Ansell of the Mayo Clinic in a short video explaining the Roadmap and its importance to the WM community
"Genomic-based Advances in WM" On March 6, 2016, Dr. Jorge Castillo spoke to the Philadelphia IWMF Support Group on Genomic-based Advances in WM. Dr. Castillo, of the Dana-Farber Cancer Institute, is one of the world’s leading clinicians for Waldenstrom’s macroglobulinemia, and provides a valuable perspective, especially since:
- There are approximately 1,500 WM patients diagnosed each year in the United States.
- Dr. Castillo sees approximately 750 WM patients each year!
- Most community oncologists see 0, 1, 2, or 3 WM patients in their career, Dr. Castillo probably sees more WM patients in a morning than most oncologists see in a lifetime.
This video is almost 2 hours in length.
"Waldenstrom's and MGUS in Families: Your Questions and Answers." Dr. Mary Lou McMaster of NIH discusses WM biology and treatments and focuses on the topic of familial WM in her presentation to the Northern Virginia IWMF Support Group in October 2014. This video is approximately 1 hour and 30 minutes in length. Anyone wishing to view it in segments can use the following as a guide: 0 to 33 minutes - general discussion of WM, IgM, and B-cell biology; 33 minutes to 1 hour - review of the principles of WM progression and treatment; 1 hour to end - familial WM and susceptibility.